Home | Structured Search | Drug Resource
Find: within
Sexual Assault > Diagnosis Author: Carolyn J. Sachs, MD, MPH
Editorial changes - 2008-05-02
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Bedside urine β-HCG testing is obtained in all women patients of childbearing age to exclude preexisting pregnancy before consideration of pregnancy and STD prophylaxis.
  • Urine, blood, or both may be requested by local crime labs for toxicology testing.
  • Crime labs request the patient's first available voided urine to optimize recovery of potential substances.
  • Perpetrator use of alcohol and other drugs to incapacitate victims and facilitate rape ("drug-facilitated sexual assault" [DFSA]) has increased in recent years.
  • Although any type of sedative or hypnotic may be used to facilitate sexual assault, the most notable drugs recently described include flunitrazepam and GHB.

Evidence:

  • Reliable tests can be done on reference samples for the patient's DNA. Two review compilations of crime lab validations studies from sexual assault cases have shown the robustness of DNA tests currently used in forensic casework (44; 45).
  • A 6-year, retrospective, emergency department case review of 1421 patients found that reported drug-facilitated sexual assault comprised 12% of cases, with large increases over the period studied. Compared to other sexual assaults, suspected drug-facilitated sexual assault cases have a longer delay in presenting to the hospital, are less likely to involve the police, and have a lower occurrence of both genital and extra-genital injury (46).
  • Obtaining the first voided urine is particularly important when GHB is the substance suspected in drug-facilitated rape, as a study had shown that peak urine concentration after single-dose ingestion of 50 mg/kg occurs within 3 hours after ingestion and may be undetectable by 12 hours post ingestion. Larger doses and illegally manufactured GHB may follow different pharmacokinetics (47).
  • Commonly used urine and blood toxicology tests for GHB have been shown to be reliable, sensitive, and specific in two crime lab experimental analyses (48; 49). Half of all sexual assaults involve intake of drugs or alcohol by the patient (50).
  • In a prospective, observational study, current lab methods detected flunitrazepam and its metabolites in urine 5 days or more after a single-dose drug intake in all 21 test subjects (51).

Comments:

  • None.

FAQs
Carolyn J. Sachs, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.